A new era in presenting patient perceptions about drug treatment to HCPs and patients
July 29, 2020
10:00AM - 11:00AM

Join us for a 1-hour webinar on the FDA's Project Patient Voice initiative to find out what this means for the future of drug development

Our perspectives on the patient-reported data from oncology studies via the FDA's Project Patient Voice.

On July 17, the FDA is holding a virtual workshop to provide a forum for open discussion between academia, industry, international regulatory, and patient advocacy groups to advance measurement of the patient experience as it relates to oncology treatment tolerability data. This is part of the FDA's pilot Project Patient Voice (PPV) initiative which is based on the development of a web-based public source of patient experience data that is accessible to patients, caregivers, and providers in support of the 21st Century Cures Act. 

This webinar will outline how PPV is taking a significant step in recognizing both tolerability and patient experience data as key elements of oncology evidence generations plans, and making this data available directly to patients. 

Join us for a compelling webinar to learn more about what PPV means for the future of drug development and key considerations to adapt in your evidence strategy to remain ahead of the competition.
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.